These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 2670511)

  • 41. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of calcium-entry blockers and diuretics in the treatment of hypertensive patients.
    Sowers JR; Mohanty PK
    Circulation; 1987 Jun; 75(6 Pt 2):V170-3. PubMed ID: 3552313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Manidipine: a review of its use in hypertension.
    Cheer SM; McClellan K
    Drugs; 2001; 61(12):1777-99. PubMed ID: 11693466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.
    Benfield P; Clissold SP; Brogden RN
    Drugs; 1986 May; 31(5):376-429. PubMed ID: 2940080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Calcium antagonists: a potent vasodilatory principle and alternative basic antihypertensive therapy].
    Bolli P; Erne P; Bühler FR
    Schweiz Med Wochenschr; 1983 Nov; 113(46):1733-5. PubMed ID: 6658418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium influx blockers in the treatment of essential hypertension.
    Hulthén UL; Bolli P; Bühler FR
    Acta Med Scand Suppl; 1984; 681():101-8. PubMed ID: 6145299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular effects of verapamil in patients with essential hypertension.
    Schmieder RE; Messerli FH; Garavaglia GE; Nunez BD
    Circulation; 1987 May; 75(5):1030-6. PubMed ID: 3568303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on verapamil in the treatment of essential hypertension: a review.
    Midtbø K; Hals O; Lauve O; van der Meer J; Storstein L
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):165S-171S. PubMed ID: 3530299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term results with verapamil in essential hypertension and its influence on serum lipids.
    Lewis GR
    Am J Cardiol; 1986 Feb; 57(7):35D-38D. PubMed ID: 3513514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium antagonist induced vasodilation in peripheral, coronary and cerebral vasculature as important factors in the treatment of elderly hypertensives.
    Erne P; Conen D; Kiowski W; Bolli P; Müller FB; Bühler FR
    Eur Heart J; 1987 Nov; 8 Suppl K():49-56. PubMed ID: 3330030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics.
    Baky SH; Singh BN
    Pharmacotherapy; 1982; 2(6):328-353. PubMed ID: 6762530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcium antagonists in the treatment of essential hypertension: review of international studies.
    Clement DL
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S7-11. PubMed ID: 2475694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.